News | September 08, 2023
Takeda emphasizes DEI to bring equal opportunities for all at the G20 Summit
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
AAT is a substantial socio-economic burden to livestock farmers in Sub-Saharan Africa, affecting and killing millions of cattle every year
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
India’s efforts are aimed at boosting health at the last mile
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Subscribe To Our Newsletter & Stay Updated
